Source:

Nursing2015

July 2004, Volume 34 Number 7 , p 8 - 8 [FREE]

Author

  • SUSAN E. SHINN RN,C, AOCN, MSN

Abstract

 

I'd like to clarify information in my article on cervical cancer ("Taking a Stand Against Cervical Cancer," May 2004). According to the research I'm seeing, the investigational drug ZYC101a is being used to treat human papillomavirus in high-grade dysplasia (or carcinoma in situ), not high-grade cervical cancer.

 

SUSAN E. SHINN, RN,C, AOCN, MSN

 

Asheville, N.C.

I'd like to clarify information in my article on cervical cancer ("Taking a Stand Against Cervical Cancer," May 2004). According to the research I'm seeing, the investigational drug ZYC101a is being used to treat human papillomavirus in high-grade dysplasia (or carcinoma in situ), not high-grade cervical cancer.

SUSAN E. SHINN, RN,C, AOCN, MSN

Asheville, N.C.

Source

 

"ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial," Obstetrics and Gynecology, F. Garcia, et al., February 2004.